Scroll for more
Why us
In highly regulated industries, success requires more than expertise, it requires precision, agility, and trust. At Runom, we bring together regulatory excellence, digital innovation, and global expertise to deliver reliable solutions that strengthen compliance, accelerate performance, and support sustainable growth.
Our Experts
At Runom, our experts operate at the intersection of regulatory excellence, digital innovation, and intelligent technologies. With extensive experience across biopharmaceutical, biotechnology, and medical technology industries, we combine deep expertise in GxP compliance, computerized systems validation (CSV), data integrity, and AI governance to help organizations navigate complex regulatory environments.
Grow with Us
At Runom, we empower talented professionals to grow, innovate, and make a meaningful impact. Through flexibility, global collaboration, and continuous development, we create an environment where ambitious people can thrive while shaping the future of regulated life sciences and digital transformation.
From Compliance
to Digital Acceleration
Validation and Qualification Services
Process Optimization & Quality
Digital & AI Acceleration
Building compliant and reliable systems for regulated environments.
Our team delivers risk-based validation and qualification services that ensure inspection readiness while reducing operational effort.
From compliance control to operational excellence.
Our experts optimizes quality management workflows to increase efficiency, simplify documentation, and strengthen sustainable process performance.
We drive innovation in regulated industries.
We enable optimal digital transformation through modern platforms, intelligent automation and AI-based solutions tailored to pharmaceutical environments.
News
14
JAN
EMA and FDA set common principles for AI in medicine development
The principles give broad guidance on AI use in evidence generation and monitoring across all phases of a medicine, from early research and clinical trials to manufacturing and safety monitoring.
16
JAN
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 12 - 15 January 2026
At its monthly meeting, EMA’s safety committee (PRAC) carried out its broad range of responsibilities, which cover all aspects of the risk management of the use of medicines: assessment of safety signals, risk management plans, periodic safety update reports and post‑authorisation safety studies.
09
FEB
Making AI Work
But how is AI actually being used in fields like health care, climate tech, education, and finance?
19
FEB
10 Breakthrough Technologies in 2026
Wanna know where tech is headed this year? MIT Technology Review has answers. They compile an annual list called “10 Breakthrough Technologies”.
Connect
with an expert
- Im Vorderdorf 8 D-79777 Ühlingen. Germany.
- contact@runom.de
